Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Tables)

v3.10.0.1
Significant Accounting Policies (Tables)
12 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of Property and Equipment Estimated Useful Lives

For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives as follows:

 

Office equipment 5 years
Lab equipment 5 years

Schedule of Weighted Average Dilutive Common Shares

The following securities are excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

 

      September 30,       September 30,  
      2018       2017  
Shares issued upon conversion of convertible notes and accrued interest   $ -       -  

Schedule of Accumulated Amortization Related to Acquired Intangible Assets

The gross carrying amounts and accumulated amortization related to acquired intangible assets as of September 30, 2018 are as follows (in thousands, except year amounts):

 

Description   Book Value
as of September 30, 2017
    Additions during the year     Total after
Additions
    Remaining life
In years
    Amortization Expense for the Year Ended September 30, 2018     Book Value
as of September 30, 2018
 
License Rights to OvaDx     1,334       -       1,334       9       167       1,167  
THI Acquisition on May 11, 2016     3,745       -       3,745       15       267       3,477  
Website development cost     4       -       4       5       1       3  
Patent costs     99       -       99       9       12       87  
Lab Equipment     -       16       16       5       1       15  
      5,181       16       5,197               448       4,749